MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
MIMETAS
Organization & Developments: MIMETAS
Parents
MIMETAS
Children
*Known for OrganoPlate technology enabling scalable, high-throughput 3D cell culture with multiple organ models like kidney and gut
*Leader in organ-on-chip-based disease models for drug discovery and development
*OrganoPlate® is the solution for all in vitro tissue culture applications.
*Since 2021, MIMETAS has engaged in a partnership strategy, focusing on disease model development and compound screening based on its proprietary high-throughput organ-on-a-chip platform.
*The platform enables unique novel tissue cultures and applications, with several versatile microfluidic designs and dedicated instruments.
2022: MIMETAS appoints Dhaval Patel as Chair of the Board of Directors
Jumps
Finance & Acquisitions: MIMETAS
Key People: MIMETAS